These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 38835755)
1. Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague. Davies ML; Biryukov SS; Rill NO; Klimko CP; Hunter M; Dankmeyer JL; Miller JA; Shoe JL; Mlynek KD; Talyansky Y; Toothman RG; Qiu J; Bozue JA; Cote CK Front Immunol; 2024; 15():1397579. PubMed ID: 38835755 [TBL] [Abstract][Full Text] [Related]
2. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague. Bowen W; Batra L; Pulsifer AR; Yolcu ES; Lawrenz MB; Shirwan H Vaccine; 2019 Sep; 37(38):5708-5716. PubMed ID: 31416643 [TBL] [Abstract][Full Text] [Related]
3. Complete Protection Against Zhang W; Song X; Zhai L; Guo J; Zheng X; Zhang L; Lv M; Hu L; Zhou D; Xiong X; Yang W Front Immunol; 2022; 13():793382. PubMed ID: 35154110 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague. Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353 [TBL] [Abstract][Full Text] [Related]
5. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734 [TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954 [TBL] [Abstract][Full Text] [Related]
7. Delivery of Tong Z; Zhang X; Guo X; Wu G; Cao S; Zhang Y; Meng X; Wang T; Wang Y; Song Y; Yang R; Du Z mSphere; 2024 Sep; 9(9):e0033024. PubMed ID: 39158304 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine. Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987 [TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine. Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064 [TBL] [Abstract][Full Text] [Related]
11. Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague. Wagner DA; Kelly SM; Petersen AC; Peroutka-Bigus N; Darling RJ; Bellaire BH; Wannemuehler MJ; Narasimhan B Acta Biomater; 2019 Dec; 100():326-337. PubMed ID: 31610342 [TBL] [Abstract][Full Text] [Related]
12. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague. Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169 [TBL] [Abstract][Full Text] [Related]
14. Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine. Airhart CL; Rohde HN; Hovde CJ; Bohach GA; Deobald CF; Lee SS; Minnich SA Vaccine; 2008 Oct; 26(44):5554-61. PubMed ID: 18722493 [TBL] [Abstract][Full Text] [Related]
15. Prevention of bubonic and pneumonic plague using plant-derived vaccines. Alvarez ML; Cardineau GA Biotechnol Adv; 2010; 28(1):184-96. PubMed ID: 19931370 [TBL] [Abstract][Full Text] [Related]
16. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Lin JS; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST Vaccine; 2010 Dec; 29(2):357-62. PubMed ID: 20840834 [TBL] [Abstract][Full Text] [Related]
17. Protection against pneumonic plague following oral immunization with a non-replicating vaccine. Jones A; Bosio C; Duffy A; Goodyear A; Schriefer M; Dow S Vaccine; 2010 Aug; 28(36):5924-9. PubMed ID: 20600517 [TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague. Kumar D; Kirimanjeswara G; Metzger DW Clin Vaccine Immunol; 2011 Nov; 18(11):1925-35. PubMed ID: 21880856 [TBL] [Abstract][Full Text] [Related]
19. A Recombinant Attenuated Singh AK; Curtiss R; Sun W Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of human antibodies from vaccinated volunteers for protection against Zhang L; Zheng B; Lu J; Wu H; Wu H; Zhang Q; Jiao L; Pan H; Zhou J Microbiol Spectr; 2024 Oct; 12(10):e0105424. PubMed ID: 39189763 [No Abstract] [Full Text] [Related] [Next] [New Search]